Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing APP13007 that is in Phase III clinical trial for the treatment of post-operative pain and inflammatory eye conditions; TSY-110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resi… Read more
Market Cap & Net Worth: Formosa Pharmaceuticals, Inc. (6838)
Formosa Pharmaceuticals, Inc. (TW:6838) has a market capitalization of $116.36 Million (NT$3.85 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #19967 globally and #1011 in its home market, demonstrating a -5.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Formosa Pharmaceuticals, Inc.'s stock price NT$25.50 by its total outstanding shares 150977000 (150.98 Million).
Formosa Pharmaceuticals, Inc. Market Cap History: 2025 to 2026
Formosa Pharmaceuticals, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $120.47 Million to $116.36 Million (0.00% CAGR).
Formosa Pharmaceuticals, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Formosa Pharmaceuticals, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6838 by Market Capitalization
Companies near Formosa Pharmaceuticals, Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Formosa Pharmaceuticals, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Formosa Pharmaceuticals, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Formosa Pharmaceuticals, Inc.'s market cap moved from $120.47 Million to $ 116.36 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$116.36 Million | -3.41% |
| 2025 | NT$120.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Formosa Pharmaceuticals, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $116.36 Million USD |
| MoneyControl | $116.36 Million USD |
| MarketWatch | $116.36 Million USD |
| marketcap.company | $116.36 Million USD |
| Reuters | $116.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.